by Meng Zhao
请关注绿🫧公号：amytheory 萌喵读文献-肿瘤学在复杂的肿瘤研究世界里，新发现层出不穷，跟上最新进展是一项挑战。别担心，萌喵来啦！我们的AI主播每天为您精选一篇最具影响力、最前沿的肿瘤学文献，用简洁明了的语言，在短短一分钟内为您解读核心内容。 特色： 🦠 聚焦肿瘤学最新突破与治疗进展 🤖 AI驱动，确保内容既专业又易懂 ⏱️ 每集仅需1分钟，效率至上 🎧 语音播报，解放双眼，随时学习 📅 工作日每日更新，紧跟研究前沿 无论您是在赶往肿瘤中心的路上，还是在实验室进行细胞培养的间隙，亦或是想在肿瘤会诊前快速了解最新进展，萌喵都是您的最佳伙伴！让我们一起探索从基础研究到临床试验的全方位肿瘤学知识。 涵盖领域： 肿瘤生物学 免疫疗法 靶向治疗 精准医疗 癌症基因组学 临床试验最新结果 订阅"萌喵读文献-肿瘤学"，让每一分钟都为攻克癌症贡献力量！喵~🐱🔬
Language
🇨🇳
Publishing Since
10/2/2024
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
November 4, 2025
科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。 本期关注Haematologica(影响因子8.2)发表的重要论文"Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration"。这项研究由Hershkovitz-Rokah O团队完成，为罕见血液疾病非朗格汉斯细胞组织细胞增多症提供了全面研究框架。研究强调，尽管MAPK通路靶向治疗已显著改善患者预后，但长期用药副作用、疾病自然史数据不足、分类系统陈旧及临床试验有限等挑战依然存在。该研究呼吁通过多机构合作建立大型注册数据库和新型临床试验，以获取高质量证据，指导这些复杂疾病的诊断、管理和预后策略，为罕见病患者带来新希望。
November 3, 2025
科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。本期关注的是发表在影响因子5.1的British Journal of Haematology上的研究"Chronic myelomonocytic leukaemia"。这项重要研究揭示了CMML作为一种独特的混合性血液肿瘤，其特征是克隆性单核细胞增多，超过90%患者存在骨髓肿瘤相关体细胞突变。研究强调当前CMML治疗多为姑息性质，而异基因造血干细胞移植是唯一可能治愈的手段。文章详细介绍了BLAST和BLAST-分子风险模型等新预后工具如何帮助确定最佳移植时机，为临床医生提供重要决策依据。这项研究对改善CMML患者的治疗选择和预后评估具有重要意义。
November 2, 2025
科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。《Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee》这项发表在影响因子高达25.3的《European Urology》期刊上的研究，展示了多参数磁共振成像(mpMRI)结合VI-RADS系统如何革新膀胱癌的诊断与分期。这项指南性文献证实，mpMRI与VI-RADS能显著提高术前分期准确性，避免不必要的重复手术，并为肌肉浸润性膀胱癌患者提供个性化治疗决策依据。nacVI-RADS还能评估治疗反应，指导保留膀胱的治疗策略，为临床医生提供标准化工具，优化患者管理流程。
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Melendez-Zajgla J
Guest
Dr Xu Y
Guest
Mayerhoefer ME
Guest
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
请关注绿🫧公号：amytheory 萌喵读文献-肿瘤学在复杂的肿瘤研究世界里，新发现层出不穷，跟上最新进展是一项挑战。别担心，萌喵来啦！我们的AI主播每天为您精选一篇最具影响力、最前沿的肿瘤学文献，用简洁明了的语言，在短短一分钟内为您解读核心内容。 特色：
🦠 聚焦肿瘤学最新突破与治疗进展 🤖 AI驱动，确保内容既专业又易懂 ⏱️ 每集仅需1分钟，效率至上 🎧 语音播报，解放双眼，随时学习 📅 工作日每日更新，紧跟研究前沿
无论您是在赶往肿瘤中心的路上，还是在实验室进行细胞培养的间隙，亦或是想在肿瘤会诊前快速了解最新进展，萌喵都是您的最佳伙伴！让我们一起探索从基础研究到临床试验的全方位肿瘤学知识。 涵盖领域：
肿瘤生物学 免疫疗法 靶向治疗 精准医疗 癌症基因组学 临床试验最新结果
订阅"萌喵读文献-肿瘤学"，让每一分钟都为攻克癌症贡献力量！喵~🐱🔬
This podcast updates daily.
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Yes, this podcast regularly features guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.